Hezkiel A. Nanda

University of Minnesota — United States

Medicine · Health Sciences

6h-index287citations23works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(13), Immune Cell Function and Interaction(12), CAR-T cell therapy research(12), SARS-CoV-2 and COVID-19 Research(2), Mitochondrial Function and Pathology(2)

Publications23 total

IL-15 complex with agonistic anti-CD40 + anti-PDL1 overcomes T cell exhaustion and drives a T-bet+ effector program for pancreatic ductal adenocarcinoma eradication 3573
The Journal of Immunology·2025Open Access
Immunotherapy promotes tumor adapted TNF-producing neutrophils that impair T cell clonal expansion and resident memory formation in pancreatic ductal adenocarcinoma 2236
The Journal of Immunology·2025Open Access
Supplementary Figure 6 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 1 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Data from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025· 1 citedOpen Access
Supplementary Tables from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 3 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 7 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 2 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 9 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary FIgure 8 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 4 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure 5 from IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8<sup>+</sup> T cells Infiltrating Pancreatic Ductal Adenocarcinoma
2025Open Access
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma
Cancer Immunology Research·2025· 4 citedOpen Access
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate
Cancer Immunology Immunotherapy·2022· 11 citedOpen Access
Brown adipose tissue involution associated with progressive restriction in progenitor competence
Cell Reports·2022· 45 citedOpen Access
Characterization of influenza A virus induced transposons reveals a subgroup of transposons likely possessing the regulatory role as eRNAs
Scientific Reports·2022· 7 citedOpen Access
Mice with diverse microbial exposure histories as a model for preclinical vaccine testing
Cell Host & Microbe·2021· 73 citedOpen Access
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
PLoS Pathogens·2021· 131 citedOpen Access
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
2020· 10 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Steven S. Shen(21), Adam L. Burrack(15), Ebony A. Miller(15), Eduardo Cruz-Hinojoza(15), Ingunn M. Stromnes(15), Zoe C. Schmiechen(14), Grant H. Hickok(14), Alexander K. Tsai(14), Jonah Z. Butler(13), Nicholas J. Maurice(13), Cara-lin Lonetree(13), A. Rizzo(13), Michael J. Geuenich(12), Chengxin Yu(12), Madeline A. Ellefson(12), Audrey L. Hilk(12), Brandon M. Larsen(12), Kieran R. Campbell(12), Ryan A. Langlois(4), Jessica K. Fiege(3)